 | • レポートコード：GIR-2104Z03182 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、循環バイオマーカーのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。循環バイオマーカーの種類別市場規模（循環DNA、循環腫瘍細胞、その他）、用途別市場規模（病院、医学研究センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・循環バイオマーカーの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Abbott Laboratories、Becton, Dickinson and Company、GE Healthcare、Epigenomics AG、Agilent Technologies、Biocept、Affymetrix、Fluxion Biosciences ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：循環DNA、循環腫瘍細胞、その他 ・用途別分析2016年-2026年：病院、医学研究センター、その他 ・循環バイオマーカーの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・循環バイオマーカーのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・循環バイオマーカーのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・循環バイオマーカーの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・循環バイオマーカーの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Circulating Biomarker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Circulating Biomarker size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Circulating Biomarker market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Circulating Biomarker market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Circulating DNA
Circulating Tumor Cells
Other
Market segment by Application can be divided into
Hospital
Medical Research Center
Others
The key market players for global Circulating Biomarker market are listed below:
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Circulating Biomarker Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Circulating Biomarker Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Circulating DNA
1.2.3 Circulating Tumor Cells
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Circulating Biomarker Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Medical Research Center
1.3.4 Others
1.4 Global Circulating Biomarker Market Size & Forecast
1.4.1 Global Circulating Biomarker Sales in Value (2016-2026))
1.4.2 Global Circulating Biomarker Sales in Volume (2016-2026)
1.4.3 Global Circulating Biomarker Price by Type (2016-2026) & (USD/MT)
1.5 Global Circulating Biomarker Production Capacity Analysis
1.5.1 Global Circulating Biomarker Total Production Capacity (2016-2026)
1.5.2 Global Circulating Biomarker Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Circulating Biomarker Market Drivers
1.6.2 Circulating Biomarker Market Restraints
1.6.3 Circulating Biomarker Trends Analysis
2 Manufacturers Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Circulating Biomarker Product and Services
2.1.4 Abbott Laboratories Circulating Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Becton, Dickinson and Company
2.2.1 Becton, Dickinson and Company Details
2.2.2 Becton, Dickinson and Company Major Business
2.2.3 Becton, Dickinson and Company Circulating Biomarker Product and Services
2.2.4 Becton, Dickinson and Company Circulating Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 GE Healthcare
2.3.1 GE Healthcare Details
2.3.2 GE Healthcare Major Business
2.3.3 GE Healthcare Circulating Biomarker Product and Services
2.3.4 GE Healthcare Circulating Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Epigenomics AG
2.4.1 Epigenomics AG Details
2.4.2 Epigenomics AG Major Business
2.4.3 Epigenomics AG Circulating Biomarker Product and Services
2.4.4 Epigenomics AG Circulating Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Agilent Technologies
2.5.1 Agilent Technologies Details
2.5.2 Agilent Technologies Major Business
2.5.3 Agilent Technologies Circulating Biomarker Product and Services
2.5.4 Agilent Technologies Circulating Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Biocept
2.6.1 Biocept Details
2.6.2 Biocept Major Business
2.6.3 Biocept Circulating Biomarker Product and Services
2.6.4 Biocept Circulating Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Affymetrix
2.7.1 Affymetrix Details
2.7.2 Affymetrix Major Business
2.7.3 Affymetrix Circulating Biomarker Product and Services
2.7.4 Affymetrix Circulating Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Fluxion Biosciences
2.8.1 Fluxion Biosciences Details
2.8.2 Fluxion Biosciences Major Business
2.8.3 Fluxion Biosciences Circulating Biomarker Product and Services
2.8.4 Fluxion Biosciences Circulating Biomarker Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Circulating Biomarker Sales by Manufacturer
3.1 Global Circulating Biomarker Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Circulating Biomarker Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Circulating Biomarker
3.4 Market Concentration Rate
3.4.1 Top 3 Circulating Biomarker Manufacturer Market Share
3.4.2 Top 6 Circulating Biomarker Manufacturer Market Share
3.5 Global Circulating Biomarker Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Circulating Biomarker Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Circulating Biomarker Market Size by Region
4.1.1 Global Circulating Biomarker Sales in Volume by Region (2016-2026)
4.1.2 Global Circulating Biomarker Revenue by Region (2016-2026)
4.2 North America Circulating Biomarker Revenue (2016-2026)
4.3 Europe Circulating Biomarker Revenue (2016-2026)
4.4 Asia-Pacific Circulating Biomarker Revenue (2016-2026)
4.5 South America Circulating Biomarker Revenue (2016-2026)
4.6 Middle East and Africa Circulating Biomarker Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Circulating Biomarker Sales in Volume by Type (2016-2026)
5.2 Global Circulating Biomarker Revenue by Type (2016-2026)
5.3 Global Circulating Biomarker Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Circulating Biomarker Sales in Volume by Application (2016-2026)
6.2 Global Circulating Biomarker Revenue by Application (2016-2026)
6.3 Global Circulating Biomarker Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Circulating Biomarker Sales by Type (2016-2026)
7.2 North America Circulating Biomarker Sales by Application (2016-2026)
7.3 North America Circulating Biomarker Market Size by Country
7.3.1 North America Circulating Biomarker Sales in Volume by Country (2016-2026)
7.3.2 North America Circulating Biomarker Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Circulating Biomarker Sales by Type (2016-2026)
8.2 Europe Circulating Biomarker Sales by Application (2016-2026)
8.3 Europe Circulating Biomarker Market Size by Country
8.3.1 Europe Circulating Biomarker Sales in Volume by Country (2016-2026)
8.3.2 Europe Circulating Biomarker Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Circulating Biomarker Sales by Type (2016-2026)
9.2 Asia-Pacific Circulating Biomarker Sales by Application (2016-2026)
9.3 Asia-Pacific Circulating Biomarker Market Size by Region
9.3.1 Asia-Pacific Circulating Biomarker Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Circulating Biomarker Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Circulating Biomarker Sales by Type (2016-2026)
10.2 South America Circulating Biomarker Sales by Application (2016-2026)
10.3 South America Circulating Biomarker Market Size by Country
10.3.1 South America Circulating Biomarker Sales in Volume by Country (2016-2026)
10.3.2 South America Circulating Biomarker Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Circulating Biomarker Sales by Type (2016-2026)
11.2 Middle East & Africa Circulating Biomarker Sales by Application (2016-2026)
11.3 Middle East & Africa Circulating Biomarker Market Size by Country
11.3.1 Middle East & Africa Circulating Biomarker Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Circulating Biomarker Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Circulating Biomarker Typical Distributors
12.3 Circulating Biomarker Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Circulating Biomarker Revenue by Type, (USD Million), 2021-2026
Table 2. Global Circulating Biomarker Revenue by Application, (USD Million), 2021-2026
Table 3. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 4. Abbott Laboratories Major Business
Table 5. Abbott Laboratories Circulating Biomarker Product and Services
Table 6. Abbott Laboratories Circulating Biomarker Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 8. Becton, Dickinson and Company Major Business
Table 9. Becton, Dickinson and Company Circulating Biomarker Product and Services
Table 10. Becton, Dickinson and Company Circulating Biomarker Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 12. GE Healthcare Major Business
Table 13. GE Healthcare Circulating Biomarker Product and Services
Table 14. GE Healthcare Circulating Biomarker Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Epigenomics AG Basic Information, Manufacturing Base and Competitors
Table 16. Epigenomics AG Major Business
Table 17. Epigenomics AG Circulating Biomarker Product and Services
Table 18. Epigenomics AG Circulating Biomarker Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Agilent Technologies Basic Information, Manufacturing Base and Competitors
Table 20. Agilent Technologies Major Business
Table 21. Agilent Technologies Circulating Biomarker Product and Services
Table 22. Agilent Technologies Circulating Biomarker Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Biocept Basic Information, Manufacturing Base and Competitors
Table 24. Biocept Major Business
Table 25. Biocept Circulating Biomarker Product and Services
Table 26. Biocept Circulating Biomarker Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Affymetrix Basic Information, Manufacturing Base and Competitors
Table 28. Affymetrix Major Business
Table 29. Affymetrix Circulating Biomarker Product and Services
Table 30. Affymetrix Circulating Biomarker Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Fluxion Biosciences Basic Information, Manufacturing Base and Competitors
Table 32. Fluxion Biosciences Major Business
Table 33. Fluxion Biosciences Circulating Biomarker Product and Services
Table 34. Fluxion Biosciences Circulating Biomarker Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Circulating Biomarker Sales by Manufacturer (2019-2021e) & (K MT)
Table 36. Global Circulating Biomarker Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Circulating Biomarker, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Circulating Biomarker Production Capacity by Company, (K MT): 2020 VS 2021
Table 39. Head Office and Circulating Biomarker Production Site of Key Manufacturer
Table 40. Global Circulating Biomarker Sales by Region (2016-2021e) & (K MT)
Table 41. Global Circulating Biomarker Sales by Region (2021-2026) & (K MT)
Table 42. Global Circulating Biomarker Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Circulating Biomarker Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Circulating Biomarker Sales by Type (2016-2021e) & (K MT)
Table 45. Global Circulating Biomarker Sales by Type (2021-2026) & (K MT)
Table 46. Global Circulating Biomarker Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Circulating Biomarker Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Circulating Biomarker Price by Type (2016-2021e) & (USD/MT)
Table 49. Global Circulating Biomarker Price by Type (2021-2026) & (USD/MT)
Table 50. Global Circulating Biomarker Sales by Application (2016-2021e) & (K MT)
Table 51. Global Circulating Biomarker Sales by Application (2021-2026) & (K MT)
Table 52. Global Circulating Biomarker Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Circulating Biomarker Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Circulating Biomarker Price by Application (2016-2021e) & (USD/MT)
Table 55. Global Circulating Biomarker Price by Application (2021-2026) & (USD/MT)
Table 56. North America Circulating Biomarker Sales by Country (2016-2021e) & (K MT)
Table 57. North America Circulating Biomarker Sales by Country (2021-2026) & (K MT)
Table 58. North America Circulating Biomarker Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Circulating Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Circulating Biomarker Sales by Type (2016-2021e) & (K MT)
Table 61. North America Circulating Biomarker Sales by Type (2021-2026) & (K MT)
Table 62. North America Circulating Biomarker Sales by Application (2016-2021e) & (K MT)
Table 63. North America Circulating Biomarker Sales by Application (2021-2026) & (K MT)
Table 64. Europe Circulating Biomarker Sales by Country (2016-2021e) & (K MT)
Table 65. Europe Circulating Biomarker Sales by Country (2021-2026) & (K MT)
Table 66. Europe Circulating Biomarker Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Circulating Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Circulating Biomarker Sales by Type (2016-2021e) & (K MT)
Table 69. Europe Circulating Biomarker Sales by Type (2021-2026) & (K MT)
Table 70. Europe Circulating Biomarker Sales by Application (2016-2021e) & (K MT)
Table 71. Europe Circulating Biomarker Sales by Application (2021-2026) & (K MT)
Table 72. Asia-Pacific Circulating Biomarker Sales by Region (2016-2021e) & (K MT)
Table 73. Asia-Pacific Circulating Biomarker Sales by Region (2021-2026) & (K MT)
Table 74. Asia-Pacific Circulating Biomarker Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Circulating Biomarker Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Circulating Biomarker Sales by Type (2016-2021e) & (K MT)
Table 77. Asia-Pacific Circulating Biomarker Sales by Type (2021-2026) & (K MT)
Table 78. Asia-Pacific Circulating Biomarker Sales by Application (2016-2021e) & (K MT)
Table 79. Asia-Pacific Circulating Biomarker Sales by Application (2021-2026) & (K MT)
Table 80. South America Circulating Biomarker Sales by Country (2016-2021e) & (K MT)
Table 81. South America Circulating Biomarker Sales by Country (2021-2026) & (K MT)
Table 82. South America Circulating Biomarker Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Circulating Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Circulating Biomarker Sales by Type (2016-2021e) & (K MT)
Table 85. South America Circulating Biomarker Sales by Type (2021-2026) & (K MT)
Table 86. South America Circulating Biomarker Sales by Application (2016-2021e) & (K MT)
Table 87. South America Circulating Biomarker Sales by Application (2021-2026) & (K MT)
Table 88. Middle East & Africa Circulating Biomarker Sales by Country (2016-2021e) & (K MT)
Table 89. Middle East & Africa Circulating Biomarker Sales by Country (2021-2026) & (K MT)
Table 90. Middle East & Africa Circulating Biomarker Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Circulating Biomarker Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Circulating Biomarker Sales by Type (2016-2021e) & (K MT)
Table 93. Middle East & Africa Circulating Biomarker Sales by Type (2021-2026) & (K MT)
Table 94. Middle East & Africa Circulating Biomarker Sales by Application (2016-2021e) & (K MT)
Table 95. Middle East & Africa Circulating Biomarker Sales by Application (2021-2026) & (K MT)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Circulating Biomarker Typical Distributors
Table 99. Circulating Biomarker Typical Customers
List of Figures
Figure 1. Circulating Biomarker Picture
Figure 2. Global Circulating Biomarker Sales Market Share by Type in 2020
Figure 3. Circulating DNA
Figure 4. Circulating Tumor Cells
Figure 5. Other
Figure 6. Global Circulating Biomarker Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Medical Research Center
Figure 9. Others
Figure 10. Global Circulating Biomarker Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 11. Global Circulating Biomarker Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Circulating Biomarker Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Circulating Biomarker Sales (2016-2026) & (K MT)
Figure 32. Global Circulating Biomarker Production Capacity (2016-2026) & (K MT)
Figure 33. Global Circulating Biomarker Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Circulating Biomarker Market Drivers
Figure 35. Circulating Biomarker Market Restraints
Figure 36. Circulating Biomarker Market Trends
Figure 37. Global Circulating Biomarker Sales Market Share by Manufacturer in 2020
Figure 38. Global Circulating Biomarker Revenue Market Share by Manufacturer in 2020
Figure 39. Circulating Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Circulating Biomarker Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Circulating Biomarker Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Circulating Biomarker Sales Market Share by Region (2016-2026)
Figure 43. Global Circulating Biomarker Revenue Market Share by Region (2016-2026)
Figure 44. North America Circulating Biomarker Revenue (2016-2026) & (USD Million)
Figure 45. Europe Circulating Biomarker Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Circulating Biomarker Revenue (2016-2026) & (USD Million)
Figure 47. South America Circulating Biomarker Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Circulating Biomarker Revenue (2016-2026) & (USD Million)
Figure 49. Global Circulating Biomarker Sales Market Share by Type (2016-2026)
Figure 50. Global Circulating Biomarker Revenue Market Share by Type (2016-2026)
Figure 51. Global Circulating Biomarker Price by Type (2016-2026) & (USD/MT)
Figure 52. Global Circulating Biomarker Sales Market Share by Application (2016-2026)
Figure 53. Global Circulating Biomarker Revenue Market Share by Application (2016-2026)
Figure 54. Global Circulating Biomarker Price by Application (2016-2026) & (USD/MT)
Figure 55. North America Circulating Biomarker Sales Market Share by Country (2016-2026)
Figure 56. North America Circulating Biomarker Revenue Market Share by Country (2016-2026)
Figure 57. North America Circulating Biomarker Sales Market Share by Type (2016-2026)
Figure 58. North America Circulating Biomarker Sales Market Share by Application (2016-2026)
Figure 59. Europe Circulating Biomarker Sales Market Share by Country (2016-2026)
Figure 60. Europe Circulating Biomarker Revenue Market Share by Country (2016-2026)
Figure 61. Europe Circulating Biomarker Sales Market Share by Type (2016-2026)
Figure 62. Europe Circulating Biomarker Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Circulating Biomarker Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Circulating Biomarker Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Circulating Biomarker Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Circulating Biomarker Sales Market Share by Application (2016-2026)
Figure 67. South America Circulating Biomarker Sales Market Share by Country (2016-2026)
Figure 68. South America Circulating Biomarker Revenue Market Share by Country (2016-2026)
Figure 69. South America Circulating Biomarker Sales Market Share by Type (2016-2026)
Figure 70. South America Circulating Biomarker Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Circulating Biomarker Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Circulating Biomarker Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Circulating Biomarker Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Circulating Biomarker Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のリキッドバイオプシー用循環バイオマーカー市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Circulating Biomarker for Liquid Biopsy Market The global Circulating Biomarker for Liquid Biopsy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…- 世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation. Asia Pacific is expected to be the fastest growth region in circulating tumor cells market over the forecast period owing to the increasi…
- 世界の循環腫瘍細胞（CTC）予後技術市場規模・現状・予測（2021年-2027年） Circulating tumor cells (CTCs) are specialized rare cells, which have been shed from a primary solid tumor of the body and circulate in the vasculature system of the body, eventually causing metastasis. CTCs act as the seeds for successive development of additional metastatic tumors in distant organ…
- 世界の循環腫瘍細胞（CTC）・がん幹細胞（CSC）市場規模・現状・予測（2021年-2027年） The tumor cells which have shed into lymphatic system and circulated over the body through blood circulation are called as circulating tumor cells. Circulating tumor cells may comprise seeds for metastasis. Stem cells are the type of cells that can differentiate into specialized cells and have the c…
- 世界の循環腫瘍細胞（CTC）市場規模・現状・予測（2021年-2027年） Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potenti…